J Med Microbiol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Molyneaux, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Molyneaux, P. J.
Agricola
Right arrow Articles by Molyneaux, P. J.

The Journal of Medical Microbiology, Vol 43, Issue 6 397-404, Copyright © 1995 by Society for General Microbiology


JOURNAL ARTICLE

Human immunity to rotavirus

P. J. Molyneaux
Regional Virus Laboratory, City Hospital, Edinburgh.

Rotaviruses are the most important cause of severe gastro-enteritis in infants and young children. However, the determinants of protective immunity are poorly understood. Human immunity to rotavirus can be acquired passively or actively. It may be humoral or cell-mediated, protective or non-protective, homotypic or heterotypic and mucosal or systemic, or any combination of these. Mucosal immunity is protective against rotavirus illness, but not against infection, whereas systemic immunity reflects exposure, but probably has little if any role in protection. Both local and cell-mediated immunity are likely to be important in protection. However, there is no agreement as to a reliable surrogate marker of small intestinal protective immunity, and little is known about small intestinal cell-mediated immunity in man, especially infants. Passive mucosal immunity, but not systemic immunity, may contribute to protection in breast-fed infants, and in those at increased risk of serious illness who have been given oral immunoglobulin, either as prophylaxis or therapeutically. Animal and adult studies may have only limited relevance to those who are at greatest risk of serious illness. However, it is probably from such studies that hypotheses about small intestinal cell-mediated immunity in the protection of infants against rotavirus infection in man remain unclear, and this continues to hinder vaccine research.


This article has been cited by other articles:


Home page
J. Virol.Home page
R. M. Kaufhold, J. A. Field, M. J. Caulfield, S. Wang, H. Joseph, M. A. Wooters, T. Green, H. F. Clark, D. Krah, and J. G. Smith
Memory T-Cell Response to Rotavirus Detected with a Gamma Interferon Enzyme-Linked Immunospot Assay
J. Virol., May 1, 2005; 79(9): 5684 - 5694.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
R. D. Newman, J. Grupp-Phelan, D. K. Shay, and R. L. Davis
Perinatal Risk Factors for Infant Hospitalization With Viral Gastroenteritis
Pediatrics, January 1, 1999; 103(1): e3 - 3.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 1995 Society for General Microbiology.